Dowling & Yahnke’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $7.53M | Buy |
33,391
+255
| +0.8% | +$61.8K | 0.35% | 73 |
|
|
2022
Q2 | $8.06M | Buy |
33,136
+854
| +3% | +$209K | 0.38% | 67 |
|
|
2022
Q1 | $7.81M | Sell |
32,282
-296
| -0.9% | -$68K | 0.34% | 86 |
|
|
2021
Q4 | $7.33M | Sell |
32,578
-1,923
| -6% | -$406K | 0.35% | 87 |
|
|
2021
Q3 | $7.34M | Sell |
34,501
-254
| -0.7% | -$58.5K | 0.41% | 79 |
|
|
2021
Q2 | $8.47M | Buy |
34,755
+358
| +1% | +$88.1K | 0.49% | 68 |
|
|
2021
Q1 | $8.56M | Sell |
34,397
-130
| -0.4% | -$31K | 0.58% | 51 |
|
|
2020
Q4 | $7.94M | Buy |
34,527
+711
| +2% | +$164K | 0.57% | 53 |
|
|
2020
Q3 | $8.6M | Sell |
33,816
-252
| -0.7% | -$62.4K | 0.69% | 39 |
|
|
2020
Q2 | $8.04M | Sell |
34,068
-429
| -1% | -$97.9K | 0.67% | 39 |
|
|
2020
Q1 | $6.99M | Sell |
34,497
-61
| -0.2% | -$13.3K | 0.67% | 43 |
|
|
2019
Q4 | $8.33M | Buy |
34,558
+212
| +0.6% | +$46.7K | 0.64% | 43 |
|
|
2019
Q3 | $6.65M | Sell |
34,346
-2,764
| -7% | -$531K | 0.55% | 61 |
|
|
2019
Q2 | $6.84M | Buy |
+37,110
| New | +$6.64M | 0.57% | 55 |
|
|
2018
Q4 | – | Sell |
-37,060
| Closed | -$7.68M | – | 256 |
|
|
2018
Q3 | $7.68M | Sell |
37,060
-439
| -1% | -$86.5K | 0.67% | 40 |
|
|
2018
Q2 | $6.92M | Sell |
37,499
-366
| -1% | -$64.7K | 0.64% | 45 |
|
|
2018
Q1 | $6.46M | Sell |
37,865
-879
| -2% | -$161K | 0.6% | 54 |
|
|
2017
Q4 | $6.74M | Buy |
38,744
+613
| +2% | +$108K | 0.61% | 56 |
|
|
2017
Q3 | $7.11M | Buy |
38,131
+254
| +0.7% | +$45K | 0.72% | 41 |
|
|
2017
Q2 | $6.52M | Sell |
37,877
-5,062
| -12% | -$823K | 0.69% | 45 |
|
|
2017
Q1 | $7.04M | Buy |
42,939
+7,347
| +21% | +$1.22M | 0.75% | 37 |
|
|
2016
Q4 | $5.2M | Buy |
35,592
+239
| +0.7% | +$36K | 0.58% | 58 |
|
|
2016
Q3 | $5.9M | Sell |
35,353
-47
| -0.1% | -$7.95K | 0.69% | 45 |
|
|
2016
Q2 | $5.39M | Buy |
35,400
+790
| +2% | +$123K | 0.65% | 49 |
|
|
2016
Q1 | $5.19M | Buy |
34,610
+984
| +3% | +$146K | 0.64% | 50 |
|
|
2015
Q4 | $5.46M | Sell |
33,626
-87
| -0.3% | -$13.7K | 0.69% | 43 |
|
|
2015
Q3 | $4.66M | Buy |
33,713
+1,336
| +4% | +$211K | 0.63% | 50 |
|
|
2015
Q2 | $4.97M | Sell |
32,377
-246
| -0.8% | -$39.4K | 0.63% | 54 |
|
|
2015
Q1 | $5.21M | Buy |
32,623
+19
| +0.1% | +$2.99K | 0.65% | 49 |
|
|
2014
Q4 | $5.19M | Sell |
32,604
-402
| -1% | -$62.6K | 0.65% | 48 |
|
|
2014
Q3 | $4.64M | Sell |
33,006
-210
| -0.6% | -$27.4K | 0.61% | 54 |
|
|
2014
Q2 | $3.93M | Buy |
33,216
+579
| +2% | +$67K | 0.51% | 68 |
|
|
2014
Q1 | $4.03M | Buy |
32,637
+665
| +2% | +$80.7K | 0.53% | 66 |
|
|
2013
Q4 | $3.65M | Buy |
31,972
+1,625
| +5% | +$185K | 0.51% | 70 |
|
|
2013
Q3 | $3.4M | Buy |
30,347
+542
| +2% | +$58.8K | 0.53% | 70 |
|
|
2013
Q2 | $2.94M | Buy |
+29,805
| New | +$3.09M | 0.49% | 74 |
|
Other funds holding AMGN
Dowling & Yahnke's AMGN Position: Q3 2022 in Review
Dowling & Yahnke increased its Amgen (AMGN) stake by 0.77% in Q3 2022, buying an estimated $61.8K and bringing the position to 33,391 shares worth $7.53M. The position accounts for 0.35% of the portfolio, ranked #73.
Dowling & Yahnke first reported a position in AMGN in Q2 2013 and has held it in 36 quarters since. The position peaked at $8.6M in Q3 2020. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Dowling & Yahnke held 33,391 shares of Amgen worth $7.53M as of Q3 2022.
- Dowling & Yahnke bought 255 Amgen shares in Q3 2022, an estimated $61.8K.
- Amgen made up 0.35% of Dowling & Yahnke's portfolio in Q3 2022, its #73 holding.
- Dowling & Yahnke first reported a position in Amgen in Q2 2013 and has held it in 36 quarters since.
- Dowling & Yahnke's Amgen position peaked at $8.6M in Q3 2020.
- 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.